Article Sidebar
Date Published:
02/12/2024
Abstract Views: 207
Views pdf: 108
Views pdf: 108
Issue
Section
Các bài báo
How to Cite
Trần, T. C., Trương, T. N., Dương, T. A., Vũ, T. H. L., Nguyễn, T. D., Nguyễn, V. H., & Lê, M. T. (2024). COST OF PRE-EXPOSURE PROPHYLAXIS FOR MSM AT GLINK CLINIC HA NOI IN 2021. Vietnam Medical Journal, 544(3). https://doi.org/10.51298/vmj.v544i3.12006
COST OF PRE-EXPOSURE PROPHYLAXIS FOR MSM AT GLINK CLINIC HA NOI IN 2021
Main Article Content
Abstract
The study describes the cost of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) at Glink Private Clinic in Hanoi from August 2021 to August 2022. The study design is cross-sectional, combined with cost analysis. The results of the study on 1,235 clients showed that the cost of PrEP treatment for MSM was 2 million 747 thousand VND/person/year (118 USD), of which the highest proportion was testing (37.19%), PrEP medication (34.98%) and operating costs (10.2%).
Article Details
Keywords
PrEP; cost of treatment, average cost, MSM
References
Cục Phòng, chống HIV/AIDS (2019), Quyết định số 146/QĐ-AIDS ngày 13/08/2019 của Cục trưởng Cục Phòng, chống HIV/AIDS ban hành Can thiệp phòng, chống HIV/AIDS cho nhóm nam có quan hệ tình dục với nam, Hà Nội. 
2. USAID (2018), PrEP Costing Guidelines.
3. Roberts DA, Barnabas RV, Abuna F, et al (2019), “The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya”, J Int AIDS Soc, 22 Suppl 4:e25296.
4. Adamson BJS, Carlson JJ, Kublin JG, Garrison LP (2017), “The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States”, Vaccines (Basel), 5(2):E13.
5. Nichols BE, Boucher CAB, van der Valk M, Rijnders BJA, van de Vijver DAMC (2016), “Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study”, Lancet Infect Dis, 16(12):1423-9.
6. Zhang L, Peng P, Wu Y, et al (2019), “Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China”, AIDS Behav, 23(2):523-33.
7. Choi H, Suh J, Lee W, et al (2020), “Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling study”, Sci Rep, 10:14609.
8. Kazemian P, Costantini S, Kumarasamy N, et al (2020), “The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India”, Clin Infect Dis, 70(4):633-42.
9. Suraratdecha C, Stuart RM, Manopaiboon C, et al (2018), “Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand”, J Int AIDS Soc, 21 Suppl 5:e25129.
10. Mangenah C, Chiwawal P, Chidawanyikal S, et al (2022), “Efficiency in PrEP Delivery: Estimating the Annual Costs of Oral PrEP in Zimbabwe”, AIDS Behav, 26(1):161-70.
MỘT SỐ YẾU TỐ ẢNH HƯỞNG ĐẾN KẾT QUẢ HÓA CHẤT DẪN ĐẦU
2. USAID (2018), PrEP Costing Guidelines.
3. Roberts DA, Barnabas RV, Abuna F, et al (2019), “The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya”, J Int AIDS Soc, 22 Suppl 4:e25296.
4. Adamson BJS, Carlson JJ, Kublin JG, Garrison LP (2017), “The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States”, Vaccines (Basel), 5(2):E13.
5. Nichols BE, Boucher CAB, van der Valk M, Rijnders BJA, van de Vijver DAMC (2016), “Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study”, Lancet Infect Dis, 16(12):1423-9.
6. Zhang L, Peng P, Wu Y, et al (2019), “Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China”, AIDS Behav, 23(2):523-33.
7. Choi H, Suh J, Lee W, et al (2020), “Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling study”, Sci Rep, 10:14609.
8. Kazemian P, Costantini S, Kumarasamy N, et al (2020), “The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India”, Clin Infect Dis, 70(4):633-42.
9. Suraratdecha C, Stuart RM, Manopaiboon C, et al (2018), “Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand”, J Int AIDS Soc, 21 Suppl 5:e25129.
10. Mangenah C, Chiwawal P, Chidawanyikal S, et al (2022), “Efficiency in PrEP Delivery: Estimating the Annual Costs of Oral PrEP in Zimbabwe”, AIDS Behav, 26(1):161-70.
MỘT SỐ YẾU TỐ ẢNH HƯỞNG ĐẾN KẾT QUẢ HÓA CHẤT DẪN ĐẦU